{"result": {"id": "44bf053f-f431-4063-a864-0538b7f446f0", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>CHINESE CIRCULATION JOURNAL<|>ORGANIZATION<|>The Chinese Circulation Journal published the Chinese guidelines for lipid management in 2023.\")\n##\n(\"entity\"<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>ORGANIZATION<|>The Chinese Journal of General Practice published the Chinese expert consensus on adult blood lipid management in communities in 2024.\")\n##\n(\"entity\"<|>EUROPEAN HEART JOURNAL<|>ORGANIZATION<|>The European Heart Journal published consensus statements from the European Atherosclerosis Society in 2020 and 2021.\")\n##\n(\"entity\"<|>CURRENT ATHEROSCLEROSIS REPORTS<|>ORGANIZATION<|>Current Atherosclerosis Reports published a study on triglyceride-rich lipoproteins in 2023.\")\n##\n(\"entity\"<|>PHARMACOLOGICAL RESEARCH<|>ORGANIZATION<|>Pharmacological Research published a study on cinaciguat's application for hyperlipidemia in 2023.\")\n##\n(\"entity\"<|>ATHEROSCLEROSIS<|>ORGANIZATION<|>Atherosclerosis published a study on dyslipidaemia prevalence in China in 2014.\")\n##\n(\"entity\"<|>BMJ OPEN<|>ORGANIZATION<|>BMJ Open published a study on dyslipidaemia in Canadian primary care settings in 2015.\")\n##\n(\"entity\"<|>VASCULAR HEALTH AND RISK MANAGEMENT<|>ORGANIZATION<|>Vascular Health and Risk Management published a study on mixed dyslipidemias in France in 2012.\")\n##\n(\"entity\"<|>JOURNAL OF CLINICAL LIPIDOLOGY<|>ORGANIZATION<|>Journal of Clinical Lipidology published a study on combined hyperlipidemia in 2021.\")\n##\n(\"relationship\"<|>JOINT COMMITTEE ON THE CHINESE GUIDELINES FOR LIPID MANAGEMENT<|>CHINESE CIRCULATION JOURNAL<|>The Joint Committee published their guidelines in the Chinese Circulation Journal<|>9\")\n##\n(\"relationship\"<|>DEVELOPMENT PANEL FOR CHINESE EXPERT CONSENSUS ON ADULT BLOOD LIPID MANAGEMENT IN COMMUNITIES<|>CHINESE JOURNAL OF GENERAL PRACTICE<|>The Development Panel published their consensus in the Chinese Journal of General Practice<|>9\")\n##\n(\"relationship\"<|>EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL<|>EUROPEAN HEART JOURNAL<|>The Consensus Panel published their statements in the European Heart Journal<|>9\")\n##\n(\"relationship\"<|>WADSTRÖM BN<|>CURRENT ATHEROSCLEROSIS REPORTS<|>Wadström BN published research in Current Atherosclerosis Reports<|>8\")\n##\n(\"relationship\"<|>JIA A<|>PHARMACOLOGICAL RESEARCH<|>Jia A published research in Pharmacological Research<|>8\")\n##\n(\"relationship\"<|>ZHAO S<|>ATHEROSCLEROSIS<|>Zhao S published research in Atherosclerosis<|>8\")\n##\n(\"relationship\"<|>ASGHARI S<|>BMJ OPEN<|>Asghari S published research in BMJ Open<|>8\")\n##\n(\"relationship\"<|>LAFOREST L<|>VASCULAR HEALTH AND RISK MANAGEMENT<|>Laforest L published research in Vascular Health and Risk Management<|>8\")\n##\n(\"relationship\"<|>GILL PK<|>JOURNAL OF CLINICAL LIPIDOLOGY<|>Gill PK published research in Journal of Clinical Lipidology<|>8\")\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751559247, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 810, "prompt_tokens": 4136, "total_tokens": 4946, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 4096}, "prompt_cache_hit_tokens": 4096, "prompt_cache_miss_tokens": 40}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: Krauss   RM,   et al.   Low?density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological,  genetic,  and  therapeutic  insights:  a consensus  statement  from  the  European Atherosclerosis Society  Consensus  Panel [J].  Eur  Heart  J,   2020,  41 (24): 2313?2330. DOI: 10.1093/eurheartj/ehz962.\n[6]       中国血脂管理指南修订联合专家委员会 . 中国血脂管理指 南(2023 年)[J]. 中国循环杂志, 2023, 38 (3): 237?271. DOI: 10.3969/j.issn.1000?3614.2023.03.001.\nJoint   Committee   on   the   Chinese   Guidelines   for   Lipid Management.  Chinese  guidelines  for  lipid  management ( 2023)   [J].   Chinese    Circulation   Journal,    2023,    38 (3): 237?271. DOI: 10.3969/j.issn.1000?3614.2023.03.001.\n[7]      社区成人血脂管理中国专家共识撰写组 . 社区成人血脂管理 中国专家共识(2024 年)[J]. 中华全科医师杂志, 2024, 23(3): 220?228. DOI: 10.3760/cma.j.cn114798?20231019?00260.      Development Panel for Chinese  Expert Consensus on Adult Blood  Lipid  Management  in   Communities.  Chinese  expert consensus on adult blood lipid management in communities\n(2024) [J].  Chin  J  Gen  Pract,  2024,  23(3):  220?228.  DOI: 10.3760/cma.j.cn114798?20231019?00260.\n[8]       Ginsberg      HN,      Packard      CJ,      Chapman       MJ,      et al. Triglyceride?rich     lipoproteins     and     their      remnants : metabolic  insights,  role  in  atherosclerotic  cardiovascular disease, and emerging therapeutic strategies?a consensus statement  from  the  European  Atherosclerosis  Society[J]. Eur   Heart  J,   2021,  42 (47): 4791?4806.   DOI:   10.1093/ eurheartj/ehab551.\n[9]      Wadstr?m     BN,    Wulff    AB,     Pedersen    KM,    et al.     Do triglyceride?rich        lipoproteins        equal        low?density lipoproteins  in  risk  of ASCVD? [J].  Curr  Atheroscler  Rep,\n\n\n2023,           25 (11):           795?803.           DOI:            10.1007/\ns11883?023?01153?8.\n[10]      Jia  A,  Jiang  H,  Liu W,  et al.  Novel  application  potential  of cinaciguat   in   the   treatment   of   mixed   hyperlipidemia through targeting  PTL/NPC1L1 and alleviating intestinal microbiota      dysbiosis      and      metabolic      disorders[J]. Pharmacol   Res,    2023,    194:   106854.   DOI:    10.1016/j. phrs.2023.106854.\n[11]      Zhao S, Wang Y, Mu Y, et al. Prevalence of dyslipidaemia in patients   treated   with   lipid?lowering   agents   in   China : results  of  the  DYSlipidemia  International  Study  (DYSIS) [J]. Atherosclerosis, 2014, 235 (2):463?469. DOI: 10.1016/ j.atherosclerosis.2014.05.916.\n[12]      Asghari   S,   Aref?Eshghi   E,   Godwin   M,   et al.   Single   and mixed  dyslipidaemia  in  Canadian  primary  care  settings: findings    from    the    Canadian     primary    care    sentinel surveillance network database[J]. BMJ Open, 2015, 5 (12): e007954. DOI: 10.1136/bmjopen?2015?007954.\n[13]       Laforest   L,   Ambegaonkar   BM,   Souchet   T,   et al.   Mixed dyslipidemias in primary care patients in  France [J]. Vasc Health   Risk   Manag,   2012,   8:  247?254.   DOI:   10.2147/ VHRM.S27668.\n[14]       Gill     PK,     Dron     JS,     Berberich    AJ,     et al.     Combined hyperlipidemia     is      genetically     similar      to     isolated hypertriglyceridemia[J]. J Clin Lipidol, 2021, 15 (1): 79?87. DOI: 10.1016/j.jacl.2020.11.\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL<|>ORGANIZATION<|>The European Atherosclerosis Society Consensus Panel published a consensus statement on low-density lipoproteins and atherosclerotic cardiovascular disease in the European Heart Journal in 2020.\")\n##\n(\"entity\"<|>JOINT COMMITTEE ON THE CHINESE GUIDELINES FOR LIPID MANAGEMENT<|>ORGANIZATION<|>The Joint Committee on the Chinese Guidelines for Lipid Management published the Chinese guidelines for lipid management in 2023 in the Chinese Circulation Journal.\")\n##\n(\"entity\"<|>DEVELOPMENT PANEL FOR CHINESE EXPERT CONSENSUS ON ADULT BLOOD LIPID MANAGEMENT IN COMMUNITIES<|>ORGANIZATION<|>The Development Panel for Chinese Expert Consensus on Adult Blood Lipid Management in Communities published a consensus on adult blood lipid management in communities in 2024 in the Chinese Journal of General Practice.\")\n##\n(\"entity\"<|>KRAUSS RM<|>PERSON<|>Krauss RM is one of the authors of the consensus statement from the European Atherosclerosis Society Consensus Panel published in the European Heart Journal in 2020.\")\n##\n(\"entity\"<|>GINSBERG HN<|>PERSON<|>Ginsberg HN is one of the authors of the consensus statement from the European Atherosclerosis Society published in the European Heart Journal in 2021.\")\n##\n(\"entity\"<|>WADSTRÖM BN<|>PERSON<|>Wadström BN is one of the authors of a study on triglyceride-rich lipoproteins and their risk of atherosclerotic cardiovascular disease published in Current Atherosclerosis Reports in 2023.\")\n##\n(\"entity\"<|>JIA A<|>PERSON<|>Jia A is one of the authors of a study on the novel application of cinaciguat in the treatment of mixed hyperlipidemia published in Pharmacological Research in 2023.\")\n##\n(\"entity\"<|>ZHAO S<|>PERSON<|>Zhao S is one of the authors of a study on the prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China published in Atherosclerosis in 2014.\")\n##\n(\"entity\"<|>ASGHARI S<|>PERSON<|>Asghari S is one of the authors of a study on single and mixed dyslipidaemia in Canadian primary care settings published in BMJ Open in 2015.\")\n##\n(\"entity\"<|>LAFOREST L<|>PERSON<|>Laforest L is one of the authors of a study on mixed dyslipidemias in primary care patients in France published in Vascular Health and Risk Management in 2012.\")\n##\n(\"entity\"<|>GILL PK<|>PERSON<|>Gill PK is one of the authors of a study on combined hyperlipidemia and its genetic similarity to isolated hypertriglyceridemia published in the Journal of Clinical Lipidology in 2021.\")\n##\n(\"relationship\"<|>KRAUSS RM<|>EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL<|>Krauss RM is one of the authors of the consensus statement published by the European Atherosclerosis Society Consensus Panel<|>8\")\n##\n(\"relationship\"<|>GINSBERG HN<|>EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL<|>Ginsberg HN is one of the authors of the consensus statement published by the European Atherosclerosis Society Consensus Panel<|>8\")\n##\n(\"relationship\"<|>WADSTRÖM BN<|>EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL<|>Wadström BN is associated with research on topics related to the European Atherosclerosis Society's focus<|>5\")\n##\n(\"relationship\"<|>JIA A<|>JOINT COMMITTEE ON THE CHINESE GUIDELINES FOR LIPID MANAGEMENT<|>Jia A is involved in research related to lipid management, similar to the focus of the Joint Committee on the Chinese Guidelines for Lipid Management<|>4\")\n##\n(\"relationship\"<|>ZHAO S<|>DEVELOPMENT PANEL FOR CHINESE EXPERT CONSENSUS ON ADULT BLOOD LIPID MANAGEMENT IN COMMUNITIES<|>Zhao S is involved in research related to lipid management, similar to the focus of the Development Panel for Chinese Expert Consensus on Adult Blood Lipid Management in Communities<|>4\")\n##\n(\"relationship\"<|>ASGHARI S<|>EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL<|>Asghari S is involved in research related to dyslipidaemia, similar to the focus of the European Atherosclerosis Society Consensus Panel<|>4\")\n##\n(\"relationship\"<|>LAFOREST L<|>EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL<|>Laforest L is involved in research related to dyslipidaemia, similar to the focus of the European Atherosclerosis Society Consensus Panel<|>4\")\n##\n(\"relationship\"<|>GILL PK<|>EUROPEAN ATHEROSCLEROSIS SOCIETY CONSENSUS PANEL<|>Gill PK is involved in research related to hyperlipidemia, similar to the focus of the European Atherosclerosis Society Consensus Panel<|>4\")\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_668d135851a1a60c5337404603927a682ec3701f3570fe7a6afcd66e28ed0670_v2"}